Search

Displaying results 1 - 10 of 10000 in total
  1. Pathway

    Ioflupane I-123 Predicted Metabolism Pathway

    smpdb.ca/view/SMP0174587
    Metabolic

    Metabolites of Ioflupane I-123 are predicted with biotransformer.

    Drugs: Mesoheme · Ioflupane I-123
  2. Pathway

    Iodohippurate sodium I-131 Drug Metabolism

    smpdb.ca/view/SMP0130590
    Metabolic

    Iodohippurate sodium I-131 passes through the liver and is then excreted from the body mainly through the kidney. … Iodohippurate sodium I-131 is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.

    Drugs: Iodohippurate sodium I-131
  3. Pathway

    Iodohippurate sodium I-123 Drug Metabolism

    smpdb.ca/view/SMP0130602
    Metabolic

    Iodohippurate sodium I-123 passes through the liver and is then excreted from the body mainly through the kidney. … Iodohippurate sodium I-123 is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.

    Drugs: Iodohippurate sodium I-123
  4. Pathway

    Rose bengal I-131 Drug Metabolism

    smpdb.ca/view/SMP0130890
    Metabolic

    Rose bengal I-131 passes through the liver and is then excreted from the body mainly through the kidney. … Rose bengal I-131 is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.

    Drugs: Rose bengal I-131
  5. Pathway

    Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate Drug Metabolism

    smpdb.ca/view/SMP0130603
    Metabolic

    Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate passes through the liver and is then excreted from the body mainly through the kidney. … Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.

    Drugs: Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate
  6. Pathway

    Cardiolipin Biosynthesis CL(i-12:0/i-12:0/i-12:0/i-13:0)

    smpdb.ca/view/SMP0051177
    Disease

    BTHS patients seem to lack acyl specificity and consequently, many potential cardiolipin species can exist (PMID: 16226238).

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  7. Pathway

    Cardiolipin Biosynthesis CL(i-12:0/i-12:0/i-12:0/i-14:0)

    smpdb.ca/view/SMP0051178
    Disease

    BTHS patients seem to lack acyl specificity and consequently, many potential cardiolipin species can exist (PMID: 16226238).

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  8. Pathway

    Cardiolipin Biosynthesis CL(i-12:0/i-12:0/i-12:0/i-18:0)

    smpdb.ca/view/SMP0051182
    Disease

    BTHS patients seem to lack acyl specificity and consequently, many potential cardiolipin species can exist (PMID: 16226238).

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  9. Pathway

    Cardiolipin Biosynthesis CL(i-12:0/i-12:0/i-13:0/i-12:0)

    smpdb.ca/view/SMP0051194
    Disease

    BTHS patients seem to lack acyl specificity and consequently, many potential cardiolipin species can exist (PMID: 16226238).

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  10. Pathway

    Cardiolipin Biosynthesis CL(i-12:0/i-12:0/i-13:0/i-20:0)

    smpdb.ca/view/SMP0051202
    Disease

    BTHS patients seem to lack acyl specificity and consequently, many potential cardiolipin species can exist (PMID: 16226238).

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate